Prothena to Participate in Oppenheimer and RBC Capital Markets Healthcare Investor Conferences
(Thomson Reuters ONE) -
DUBLIN, Ireland., Dec. 01, 2015 (GLOBE NEWSWIRE) -- Prothena Corporation plc
(NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the
discovery, development and commercialization of novel protein immunotherapies,
today announced that members of its senior management team will participate in
two upcoming investor meetings:
* Oppenheimer 26th Annual Healthcare Conference on December 8-9, 2015 in New
York, NY. Prothena will present an update on its business on December
8th at 8:00 AM ET.
* RBC Capital Markets Healthcare Investor Day on December 10, 2015 in Denver,
CO
A live webcast of the presentation from the Oppenheimer conference can be
accessed through the investor relations section of the Company's website at
www.prothena.com. Following the live presentation, replays of the webcasts will
be available on the Company's website for at least 90 days following the
presentation date.
About Prothena
Prothena Corporation plc is a late-stage clinical biotechnology company focused
on the discovery, development and commercialization of novel protein
immunotherapy programs for the potential treatment of diseases that involve
amyloid or cell adhesion. The company is developing antibody-based product
candidates that target a number of potential indications including AL
amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies
(PRX002), and psoriasis and other inflammatory diseases (PRX003).
For more information, please visit the company's web site at www.prothena.com.
Investors: Tran Nguyen, CFO
650-837-8535, IR(at)prothena.com
Media: Ellen Rose
650-922-2405, ellen.rose(at)prothena.com
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Prothena Corporation plc via GlobeNewswire
[HUG#1967855]
Unternehmensinformation / Kurzprofil:
Datum: 01.12.2015 - 22:05 Uhr
Sprache: Deutsch
News-ID 436908
Anzahl Zeichen: 2425
contact information:
Town:
DUBLIN
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 354 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Prothena to Participate in Oppenheimer and RBC Capital Markets Healthcare Investor Conferences"
steht unter der journalistisch-redaktionellen Verantwortung von
Prothena Corporation plc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
